carvedilol has been researched along with ibuprofen in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baumgartner, S; Kocbek, P; Kristl, J; Lavrič, Z; Planinšek, O; Potrč, T; Roškar, R | 1 |
| Genina, N; Hadi, B; Löbmann, K | 1 |
| Brede, K; Genina, N; Hempel, NJ; Knopp, MM; Löbmann, K; Olesen, NE | 1 |
| Grohganz, H; Hempel, NJ; Kissi, EO; Löbmann, K; Rades, T; Ruggiero, MT; Song, Z | 1 |
| Chen, P; Fang, L; Han, X; Jiang, Z; Li, S; Wang, C; Wang, J; Zhao, L; Zhao, Y | 1 |
2 review(s) available for carvedilol and ibuprofen
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for carvedilol and ibuprofen
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs.
Topics: Administration, Oral; Calorimetry, Differential Scanning; Carbazoles; Carvedilol; Drug Delivery Systems; Ibuprofen; Microscopy, Electron, Scanning; Mouth Mucosa; Nanofibers; Polyesters; Propanolamines; Solubility; Technology, Pharmaceutical; Water | 2015 |
Hot Melt Extrusion as Solvent-Free Technique for a Continuous Manufacturing of Drug-Loaded Mesoporous Silica.
Topics: Carbazoles; Carvedilol; Chemistry, Pharmaceutical; Drug Compounding; Hot Temperature; Ibuprofen; Polyethylene Glycols; Polymers; Polyvinyls; Propanolamines; Silicon Dioxide; Solubility; Solvents | 2018 |
A fast and reliable DSC-based method to determine the monomolecular loading capacity of drugs with good glass-forming ability in mesoporous silica.
Topics: Calorimetry, Differential Scanning; Carbazoles; Carvedilol; Cinnarizine; Drug Stability; Glass; Ibuprofen; Indomethacin; Porosity; Propanolamines; Silicon Dioxide | 2018 |
Characterising glass transition temperatures and glass dynamics in mesoporous silica-based amorphous drugs.
Topics: Calorimetry, Differential Scanning; Carvedilol; Drug Liberation; Drug Stability; Glass; Ibuprofen; Molecular Dynamics Simulation; Silicon Dioxide; Transition Temperature | 2019 |
Preparation of a thiols β-cyclodextrin/gold nanoparticles-coated open tubular column for capillary electrochromatography enantioseparations.
Topics: Albuterol; Azabicyclo Compounds; beta-Cyclodextrins; Capillary Electrochromatography; Carvedilol; Gold; Ibuprofen; Metal Nanoparticles; Phenoxybenzamine; Piperazines; Stereoisomerism; Terbutaline | 2020 |